SCHEMBL14860902

SCHEMBL14860902

c1ccc([Si](c2ccccc2)(c2ccc(-c3cccnc3)cc2)c2ccc(-c3cccnc3)cc2)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 6/20 0.60
ALDH1A1 P00352 3/20 0.60
CYP3A4 P08684 2/20 0.60
CYP1A2 P05177 1/20 0.60
MKNK1 Q9BUB5 4/20 0.55
MKNK2 Q9HBH9 4/20 0.55
CYP19A1 P11511 3/20 0.52
CYP11B2 P19099 2/20 0.52
KIF11 P52732 1/20 0.52
CYP17A1 P05093 1/20 0.52
CYP11B1 P15538 1/20 0.52
KDM4E B2RXH2 2/20 0.49
TP53 P04637 2/20 0.49
MAPT P10636 2/20 0.49
HPGD P15428 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
HSD17B10 Q99714 2/20 0.49
NPC1 O15118 1/20 0.49
RAB9A P51151 1/20 0.49
CA12 O43570 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21407077 0.88 CYP2A6 (0.47) CYP2A6ALDH1A1CYP3A4CYP1A2MKNK1
SCHEMBL3400752 0.87 CYP2A6 (0.79) CYP2A6ALDH1A1CYP3A4CYP1A2MKNK1
SCHEMBL29468039 0.87 CYP2A6 (0.79) CYP2A6ALDH1A1CYP3A4CYP1A2MKNK1
SCHEMBL27634806 0.85 CYP2A6 (0.75) CYP2A6ALDH1A1CYP3A4CYP1A2MKNK1
SCHEMBL16405704 0.85 CYP2A6 (0.83) CYP2A6ALDH1A1CYP3A4CYP1A2MKNK1
SCHEMBL141605 0.85 CYP2A6 (0.83) CYP2A6ALDH1A1CYP3A4CYP1A2MKNK1
SCHEMBL29500136 0.85 CYP2A6 (0.83) CYP2A6ALDH1A1CYP3A4CYP1A2MKNK1
Biphenyl SCHEMBL28338714 0.85 CYP2A6 (0.83) CYP2A6ALDH1A1CYP3A4CYP1A2MKNK1
SCHEMBL32684289 0.85 CYP2A6 (0.56) CYP2A6ALDH1A1CYP3A4CYP1A2MKNK1
SCHEMBL30963953 0.83 CYP2A6 (0.79) CYP2A6ALDH1A1CYP3A4CYP1A2MKNK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 403 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3796409-B1 ELECTROLUMINESCENT DEVICE, AND DISPLAY DEVICE COMPRISING SAME SAMSUNG ELECTRONICS CO LTD (KR) 2025-01-15 EP claimed
CN-116096127-A Laminated light-emitting field effect transistor and preparation method and application thereof 中国科学院化学研究所 2023-05-09 CN claimed
US-11495764-B2 Electroluminescent device, and display device comprising same SAMSUNG ELECTRONICS CO., LTD. (KR) 2022-11-08 US claimed
CN-114940684-A White light luminescent copper halide complex and preparation method and application thereof 浙江大学温州研究院 2022-08-26 CN claimed
CN-109713098-B Light emitting diode and light emitting apparatus including the same 乐金显示有限公司 2022-01-28 CN claimed
US-20210091327-A1 ELECTROLUMINESCENT DEVICE, AND DISPLAY DEVICE COMPRISING SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-03-25 US claimed
EP-3796409-A1 ELECTROLUMINESCENT DEVICE, AND DISPLAY DEVICE COMPRISING SAME Samsung Electronics Co., Ltd. (KR) 2021-03-24 EP claimed
US-20200106023-A1 Thermally Activated Delayed Material and Organic Photoelectric Device Comprising the Same Shanghai Tianma AM-OLED Co., Ltd. (CN) 2020-04-02 US claimed
EP-3230295-B1 AMINO PHOSPHAZENE BASES AS N-DOPANTS IN ORGANIC ELECTRONICS SIEMENS AG (DE) 2019-07-31 EP claimed
US-10361376-B2 Proazaphosphatranes as n-dopants in organic electronics SIEMENS AKTIENGESELLSCHAFT (DE) 2019-07-23 US claimed
EP-3233873-B1 PROAZAPHOSPHATRANES AS N-DOPANTS IN ORGANIC ELECTRONICS SIEMENS AG (DE) 2019-06-26 EP claimed
CN-109713098-A Light emitting diode and luminaire including the light emitting diode 乐金显示有限公司 2019-05-03 CN claimed
US-20190131557-A1 LIGHT-EMITTING DIODE AND LIGHT-EMITTING DEVICE INCLUDING THE SAME LG DISPLAY CO., LTD. (KR) 2019-05-02 US claimed
US-10230050-B2 Amino phosphazene bases as n-dopants in organic electronics SIEMENS AKTIENGESELLSCHAFT (DE) 2019-03-12 US claimed
US-20180019396-A1 Amino Phosphazene Bases As N-Dopants In Organic Electronics SIEMENS AKTIENGESELLSCHAFT (DE) 2018-01-18 US claimed
US-20180006240-A1 Proazaphosphatranes As N-Dopants In Organic Electronics SIEMENS AKTIENGESELLSCHAFT (DE) 2018-01-04 US claimed
US-20170354016-A1 AC ELECTROLUMINESCENCE DEVICE AND FINGER SCAN SENSOR PLATFORM USING THE SAME UNIVERSITY-INDUSTRY FOUNDATION (UIF), YONSEI UNIVERSITY (KR) 2017-12-07 US claimed
US-20150097167-A1 ORGANIC LIGHT EMITTING DEVICE AND ORGANIC LIGHT EMITTING DISPLAY HAVING THE SAME LG DISPLAY CO., LTD. (KR) 2015-04-09 US claimed
US-20260120949-A1 CHARGE OR ELECTRICITY GENERATING DEVICES AND METHODS OF MAKING AND USE THEREOF OHIO STATE INNOVATION FOUNDATION (US) 2026-04-30 US disclosed
WO-2013055138-A2 SIMPLIFIED ORGANIC LIGHT EMITTING DEVICE AND MANUFACTURING METHOD THEREOF 포항공과대학교 산학협력단 (KR) 2013-04-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10361376-B2 Proazaphosphatranes as n-dopants in organic electronics PNP, NUDT1, SLC29A1 CYP2A6 1815/4885ALDH1A1 2317/4885CYP3A4 930/4885
US-10230050-B2 Amino phosphazene bases as n-dopants in organic electronics PHOSPHO1, SLC29A1, NME2 CYP2A6 4062/4885ALDH1A1 1960/4885CYP3A4 2833/4885
US-20260120949-A1 CHARGE OR ELECTRICITY GENERATING DEVICES AND METHODS OF MAKING AND USE THEREOF SLC9A2, SLC9A3, SLC9A1 CYP2A6 3335/4885ALDH1A1 3795/4885CYP3A4 967/4885
US-20200106023-A1 Thermally Activated Delayed Material and Organic Photoelectric Device Comprising the Same MAPK9, CDK9, CDK19 CYP2A6 2459/4885ALDH1A1 2695/4885CYP3A4 639/4885
US-20180006240-A1 Proazaphosphatranes As N-Dopants In Organic Electronics PNP, NUDT1, SLC29A1 CYP2A6 1815/4885ALDH1A1 2317/4885CYP3A4 930/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.